Dodick DW (2018) Migraine. Lancet 391(10127):1315–1330

Article  PubMed  Google Scholar 

Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19(2):109–117

Article  PubMed  Google Scholar 

Ashina M, Buse DC, Ashina H et al (2021) Migraine: integrated approaches to clinical management and emerging treatments. Lancet 397(10283):1505–1518

Article  PubMed  Google Scholar 

McKinley EC, Lay CL, Rosenson RS et al (2021) Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adults. J Headache Pain 22(1):124

Article  PubMed  PubMed Central  Google Scholar 

Favoni V, Giani L, Al-Hassany L et al (2019) CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP? J Headache Pain 20(1):27

Article  PubMed  PubMed Central  Google Scholar 

Kalkman DN, Couturier EGM, El Bouziani A et al (2023) Migraine and cardiovascular disease: what cardiologists should know. Eur Heart J 44(30):2815–2828

Article  CAS  PubMed  Google Scholar 

Cho J, Park J, Jo H et al (2024) Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969–2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database. J Stroke 26(3):463–467

Article  PubMed  PubMed Central  Google Scholar 

Eigenbrodt AK, Ashina H, Khan S et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501–514

Article  PubMed  PubMed Central  Google Scholar 

Kim TH, Lee K, Park S et al (2024) Association between glucagon-like peptide-1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database. Diabetes Obes Metab 26(11):5183–5191

Article  CAS  PubMed  Google Scholar 

Lee S, Jo H, Lee H et al (2024) Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database. J Med Virol 96(6):e29693

Article  CAS  PubMed  Google Scholar 

Schoretsanitis G, Weiler S, Barbui C, Raschi E, Gastaldon C (2024) Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality. JAMA Netw Open 7(8):e2423385

Article  PubMed  PubMed Central  Google Scholar 

Yang JM, Jung SY, Kim MS et al (2024) Cardiovascular and Cerebrovascular Adverse Events Associated with Intravitreal Anti-VEGF Monoclonal Antibodies: A World Health Organization Pharmacovigilance Study. Ophthalmology 132(1):62–78

Article  PubMed  Google Scholar 

Jeong YD, Lee K, Park J et al (2024) Global burden of vaccine-associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database. Allergy 80(2):590

Article  PubMed  Google Scholar 

Oh J, Jo H, Park J et al (2024) Global burden of vaccine-associated rheumatic diseases and their related vaccines, 1967–2023: A comprehensive analysis of the international pharmacovigilance database. Int J Rheum Dis 27(8):e15294

Article  PubMed  Google Scholar 

Miyata K, Izawa-Ishizawa Y, Tsujinaka K et al (2024) Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments. Biomed Pharmacother 179:117418

Article  CAS  PubMed  Google Scholar 

Elgendy IY, Nadeau SE, BaireyMerz CN, Pepine CJ (2019) Migraine Headache: An Under-Appreciated Risk Factor for Cardiovascular Disease in Women. J Am Heart Assoc 8(22):e014546

Article  PubMed  PubMed Central  Google Scholar 

Hwang J, Park SH, Lee SW et al (2021) Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. Eur Heart J 42(39):4053–4063

Article  CAS  PubMed  Google Scholar 

Ziff OJ, Samra M, Howard JP et al (2020) Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment. BMC Med 18(1):103

Article  PubMed  PubMed Central  Google Scholar 

Dodick DW, Shewale AS, Lipton RB et al (2020) Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data. J Prim Care Community Health 11:2150132720963680

Article  PubMed  PubMed Central  Google Scholar 

Ashina M, Terwindt GM, Al-Karagholi MA et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 397(10283):1496–1504

Article  CAS  PubMed  Google Scholar 

Dodick DW, Lipton RB, Ailani J et al (2019) Ubrogepant for the Treatment of Migraine. N Engl J Med 381(23):2230–2241

Article  CAS  PubMed  Google Scholar 

Benemei S, Cortese F, Labastida-Ramírez A et al (2017) Triptans and CGRP blockade - impact on the cranial vasculature. J Headache Pain 18(1):103

Article  PubMed  PubMed Central  Google Scholar 

Al-Karagholi MA, Kalatharan V, Fagerberg PS, Amin FM (2023) The vascular role of CGRP: a systematic review of human studies. Front Neurol 14:1204734

Article  PubMed  PubMed Central  Google Scholar 

Kurth T, Rohmann JL, Shapiro RE (2018) Migraine and risk of cardiovascular disease. BMJ 360:k275

Article  PubMed  Google Scholar 

Kurth T, Rist PM (2023) Migraines and cardiovascular disease: mechanisms and methodological challenges. Nat Rev Cardiol 20(12):791–792

Article  PubMed  Google Scholar 

Cho H, Lee K, Jeong YD et al (2024) Global burden of ADHD medication-associated cardiovascular disease, 1967–2023: A comparative analysis using the WHO pharmacovigilance database. Asian J Psychiatr 101:104209

Article  PubMed  Google Scholar 

Goadsby PJ, Reuter U, Hallström Y et al (2017) A Controlled Trial of Erenumab for Episodic Migraine. N Engl J Med 377(22):2123–2132

Article  CAS  PubMed  Google Scholar 

Sacco S, Amin FM, Ashina M et al (2022) European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update. J Headache Pain 23(1):67

Article  PubMed  PubMed Central  Google Scholar 

Toyoda K, Yoshimura S, Nakai M et al (2022) Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol 79(1):61–69

Article  PubMed  Google Scholar 

van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ (2010) Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 9(2):167–176

Article  PubMed  Google Scholar 

GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20(10):795–820. https://doi.org/10.1016/S1474-4422(21)00252-0

Article  Google Scholar 

Gougis P, Jochum F, Abbar B et al (2024) Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective. EClinicalMedicine 70:102536

Article  PubMed  PubMed Central  Google Scholar 

Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N (2007) Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther 82(2):157–166

Article  CAS